Data released by Eurostat, the statistical office of the European Union (EU), highlight significant variation in the standardised mortality rate for prostate cancer across the region.
The data show that in 2016, a total of 76,900 men in the EU died from malignant neoplasm of the prostate.
The standardised mortality rate (three-year average 2014-2016) stood at 39 deaths per 100,000 male EU inhabitants; however, this figure varied from just under 23 deaths per 100,000 to 77 deaths per 100,000.
With at least 60 deaths per 100,000, the highest rates were recorded in the regions of Guadeloupe and Martinique in France; in single regions of Estonia, Latvia, Sweden and Denmark; in regions of Portugal; Lithuania; the eastern half of Slovenia; and the central region of Slovakia.
The lowest standardised rates were largely concentrated in southern Europe. The rate was below 30 per 100,000 male inhabitants in 18 regions in Italy, five regions in Greece, four regions in Spain, three regions in France, two regions in Romania and one region in Bulgaria and Malta.